成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

上海一飛生物科技有限公司 公司信息

公司名稱: 上海一飛生物科技有限公司
電話: 021-65675885
電子郵件:customer_service@efebio.com
國籍:中國
網(wǎng)址: http://www.efebio.com
產品總數(shù):11973

公司提供產品列表

SR4554 167648-73-9
Sulesomab 167747-19-5
Felvizumab 167747-20-8
GNE-0946 1677667-24-1
Faralimomab 167816-91-3
(R)-VX-11e 1680187-43-2
DJ4 1681020-24-5
PG 34 1681056-62-1
Propofol-d17 β-D glucuronide 1683581-05-6
Rosmantuzumab 1684393-04-1
Dyrk1A-IN-5 1685235-41-9
Cynandione A 168706-29-4
YM-58790 168830-70-4
αvβ1 integrin-IN-1 1689540-62-2
Flupyrimin 1689566-03-7
Obexelimab 1690307-05-1
Lanepitant 170566-84-4
ARTD10/PARP10-IN-1 1708103-76-7
1-vinylpyrene 17088-21-0
Frunevetmab 1708936-80-4
Emapalumab 1709815-23-5
Sodium zirconium cyclosilicate 17141-74-1
Igovomab 171656-50-1
Piprozolin 17243-64-0
tert-Butyl (6-iodohexyl)carbamate 172846-36-5
Inophyllum E 17312-31-1
NDH-1 inhibitor-1 173964-49-3
(E)-3-(2-Chloro-4-fluorophenyl)acrylic acid 174603-37-3
Keliximab 174722-30-6
Tidembersat 175013-73-7
BODIPY FL prazosin 175799-93-6
Tagatose 17598-81-1
Roxifiban acetate 176022-59-6
CYP1B1-IN-5 176442-56-1
Izonsteride 176975-26-1
3,4,5-Trihydroxycinnamic acid decyl ester 1770778-45-4
MMP2-IN-2 1772-39-0
Phenmedipham-d3 1773497-41-8
ATX-002 1777792-34-3
Sarizotan 2HCl 177976-12-4
Opaviraline 178040-94-3
Telisotuzumab 1781223-80-0
BMS-599626 2HCL(714971-09-2 Free base) 1781932-33-9
RKI-1447 dihydrochloride 1782109-09-4
ML 120B dihydrochloride 1782573-78-7
Xanthine amine congener hydrochloride 1783977-95-6
LDN-209929 dihydrochloride 1784281-97-5
FK 866 hydrochloride (658084-64-1 free base) 1785666-54-7
NLRP3/AIM2-IN-3 1787787-60-3
Gosuranemab 1788032-39-2
UC-781 178870-32-1
Nav1.7-IN-3 1788872-06-9
Basiliximab 179045-86-4
WAY-639228 179051-05-9
Remtolumab 1791410-27-9
Lutikizumab 1791411-57-8
Elezanumab 1791416-49-3
Dilpacimab 1791420-09-1
(2R,5S)-Ritlecitinib 1792180-79-0
Vunakizumab 1792181-33-9
SB-237376 179258-59-4
SB-237376 HCl 179258-62-9
Porgaviximab 1792982-55-8
Crizanlizumab 1690318-25-2
DP00477 169120-56-3
CCT245232 1693731-14-4
SXC 2023 1695562-36-7
Nonabine 16985-03-8
Anisperimus 170368-04-4
Cevidoplenib 1703788-21-9
NLRP3-IN-13 1704638-35-6
AZ-PFKFB3-67 1704741-11-6
Lanepitant 2HCl 170508-05-1
Larcaviximab 1792982-56-9
Cosfroviximab 1792982-57-0
ER-34122 179325-62-3
Sacituzumab 1796566-95-4
Netakimab 1796570-08-5
PF-04822163 1798334-07-2
GPR40 agonist 6 1798751-25-3
GNF6702 1799329-72-8
Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc 1799711-31-1
Gremubamab 1800381-36-5
Odronextamab 1801338-64-6
Cemiplimab 1801342-60-8
RYL-552 1801444-56-3
Losatuxizumab 1801544-27-3
KL044 1801856-93-8
ABBV-318 1802848-94-7
RN-1665 1803003-65-7
Ravulizumab 1803171-55-2
Oleclumab 1803176-05-7
ZY-444 1802650-31-2
Minzasolmin 1802518-92-8
SR12418 1801185-08-9
Oleoylestrone 180003-17-2
BCAT-IN-2 1800024-45-6
RYL-552S 1801444-69-8
Vutiglabridin 1800188-47-9
GSK180 1799725-26-0
Copyright 2007? ChemicalBook. All rights reserved.